A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

NCT04182100 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

NCT05481151 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate P1101 in Japanese PV Patients

NCT06002490 ·Status: COMPLETED ·Phase: PHASE3

Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT06134414 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)

NCT04983264 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

NCT06290765 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT06050226 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of BRL-101 in Severe SCD

NCT06300723 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat

NCT04610866 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Real-world Ruxolitinib Experience in PV

NCT06251102 ·Status: NOT_YET_RECRUITING

Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease

NCT06287086 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

NCT06985147 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

NCT04119050 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

NCT05577312 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants

NCT05036512 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study of BRL-101 in the Treatment of Sickle Cell Disease

NCT06287099 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major

NCT06291961 ·Status: COMPLETED ·Phase: PHASE1

AB1 in Adult Patients with Sickle Cell Disease (SCD)

NCT05261711 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Dose-Escalation Study of SCD-101 in Sickle Cell Disease

NCT02380079 ·Status: UNKNOWN ·Phase: PHASE1

Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

NCT02252159 ·Status: COMPLETED

Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea.

NCT05421104 ·Status: COMPLETED

A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants

NCT05015920 ·Status: COMPLETED ·Phase: NA

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

NCT06546670 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT06745622 ·Status: RECRUITING ·Phase: PHASE2

Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major

NCT01206075 ·Status: COMPLETED ·Phase: NA